Challenges in myasthenia gravis: Management and the need for sustained treatment response
This webinar explores the evolving landscape of Myasthenia Gravis management, detailing a decade of treatment advancements. Leading neurologists discuss novel targeted therapies, including complement and FcRn inhibitors, which offer improved disease control and significant prednisone reduction. The session emphasizes precision medicine, patient-centered care, and the challenges in optimizing treatment strategies for diverse patient populations.Speaker: Massimiliano Filosto,Nils Erik Gilhus,Lorenzo Maggi,Elena Cortes Vicente
Level: Advanced
Topics in this course:
